Brandinium

Trademark search for:

APOLLO ADVANCES IN PREVENTION THROUGH OPTIMAL LIPID LOWERING

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2003-12-17 — Application filed
  • 2004-01-06 — Application filed
  • 2004-01-16 — Teas voluntary amendment received
  • 2004-03-26 — Teas change of correspondence received
  • 2004-07-14 — Assigned to examiner
  • 2004-07-21 — Final disposition recorded
  • 2005-01-19 — Paper received
  • 2005-01-19 — Correspondence received in law office
  • 2005-02-11 — Amendment from applicant entered
  • 2005-02-15 — Approved for pub - principal register
  • 2005-02-18 — Assigned to lie
  • 2005-03-02 — Law office publication review completed
  • 2005-05-25 — Notice of publication
  • 2005-06-14 — Published for opposition
  • 2005-09-06 — Noa mailed - sou required from applicant
  • 2006-03-03 — Sou teas extension received
  • 2006-03-03 — Sou extension 1 filed
  • 2006-03-21 — Sou extension 1 granted
  • 2006-06-02 — Teas change of correspondence received
  • 2006-08-17 — Sou teas extension received
  • 2006-08-17 — Sou extension 2 filed
  • 2006-09-15 — Sou extension 2 granted
  • 2007-02-20 — Sou teas extension received
  • 2007-02-20 — Sou extension 3 filed
  • 2007-05-12 — Sou extension 3 granted
  • 2007-07-23 — Attorney/dom.rep.revoked and/or appointed
  • 2007-07-23 — Teas revoke/app/change addr of atty/dom rep received
  • 2007-09-06 — Teas statement of use received
  • 2007-09-06 — Use amendment filed
  • 2007-09-06 — Office action issued
  • 2007-09-12 — Statement of use processing complete
  • 2007-10-02 — Allowed principal register - sou accepted
  • 2007-11-05 — Law office registration review completed
  • 2007-11-05 — Assigned to lie
  • 2007-12-11 — Registered-principal register
  • 2014-07-18 — Cancelled sec. 8 (6-yr)
  • 2014-07-18 — Final status recorded

Owner Information

AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE
AstraZeneca AB
Sodertalje SE

Correspondent

Wm. Charles Saunders AstraZeneca Pharmaceuticals LP
OW2
1800 Concord Pike
Wilmington, DE 19850

Filing Details

Filing Date:
2003-12-17
Status Date:
2014-07-18
Category:
Education & Entertainment
Filing Year:
2003

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.